Netskope shares have fallen precipitously this morning. At this writing they are down by 18.55%.  The fall has several authors-for me, the one that is most significant was the relatively slower growth in net new ARR this quarter which was down from a year-earlier period and at a low ebb compared to historical attainment. I…

To access this post, you must subscribe.

Read More

After yesterday’s spike in shares of most high-growth software companies, the market has cooled down quite a bit and is giving the high growth portfolio the opportunity to add to some positions where there have been positive developments and negative share price reaction. Much of yesterday’s spike was a function of what I think was…

To access this post, you must subscribe.

Read More

Yesterday saw 3 companies in the high growth portfolio report. They all beat and they all raised. Really! But stock prices for Braze and Everpure were in reverse after the earnings releases and conference calls. Most of that is likely a function of buying the rumor and selling the news. Snowflake, like Datadog a few…

To access this post, you must subscribe.

Read More

Shares of Dell continued to spike this morning. The spike is in anticipation of the upcoming earnings release. In perhaps an excess of caution, I decided to make a final trim of the Dell position before the earnings release. The Income/Stability portfolio sold 150 shares of Dell at $308.19. Dell shares have appreciated by more than 42%…

To access this post, you must subscribe.

Read More

Overnight, Nebius sent notices to its customers regarding a price increase as follows: The price for on-demand (PAYG) capacity will increase by an average 29%, and the price for preemptible (PVM) capacity will increase by 51%. The hike does not apply to existing customers. NBIS Reportedly Sees Record Demand “This update reflects continued strong demand…

To access this post, you must subscribe.

Read More

I made some changes in the High Growth portfolio this morning. I sold half of the Datadog position after its recent run. I think the shares are likely to consolidate after a 66% run in the past month. I decided to redeploy the funds to other positions that I believe have a grade potential for…

To access this post, you must subscribe.

Read More

The High Growth portfolio added to its minimal position in TempusAI shares. 500 shares were added at a price of $42.79 which cost $21, 405. We now have 750 shares of Tempus which has a weight of 1.38% in the high growth portfolio. We may add to the position to get the weight to a reasonable level.…

To access this post, you must subscribe.

Read More

Evgeny Gromov/iStock via Getty Images A healthcare technology company that uses AI as the basis for its solutions! Tempus Ai is probably not the best known company in the AI space at this stage of its evolution although it was named by Time Magazine as one of the 10 most influential software companies in a recent article.…

To access this post, you must subscribe.

Read More

Snowflake is set to report its earnings for the quarter ended April 30 later this month. While it has bounced some in the last month, it is still down more than 30% since the start of the year. The shares have been weak today, and we added to our position. Anecdotal checks suggest that usage…

To access this post, you must subscribe.

Read More